生物标志物 生物标志物
Taiki Sugimoto1,2, Paul K Crane1, Kazuaki Uchida2
1University of Washington, Seattle, WA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
双基化酶-4 (DPP-4) 抑制剂可以通过降低化陶181 (p-tau181) 水平来减缓2型糖尿病患者阿尔茨海默病的进展. 需要进一步的研究来证实这些有希望的发现.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 老年学是一门学科.
背景情况:
- 临床前研究表明DPP-4抑制剂可以减少阿尔茨海默病的病理学.
- 人类对DPP-4抑制剂对痴呆症生物标志物影响的数据有限.
- 这项研究研究了DPP-4抑制剂的使用和2型糖尿病中痴呆症生物标志物.
研究的目的:
- 检查DPP-4抑制剂使用与与痴呆相关的血生物标志物变化之间的关联.
- 为了评估酸化的tau 181 (p-tau181),神经纤维光链 (NfL) 和状纤维酸蛋白 (GFAP) 的水平.
- 为了探索2型糖尿病的老年人中这些关联.
主要方法:
- 对J-MINT试验的后期分析,该试验涉及43名2型糖尿病患者.
- 血生物标志物 (p-tau181,NfL,GFAP) 用SimoaTM平台测量了18个月的时间.
- 在基线测量Aβ复合生物标志物;用于关联分析的多重线性回归.
主要成果:
- DPP-4抑制剂使用者 (n=28) 的基线Aβ复合生物标志物水平比非使用者低.
- 与非使用者相比,使用者在18个月内p-tau181的增加明显较小.
- 对于NfL或GFAP水平,没有发现显著的关联.
结论:
- 这些发现支持临床前证据,即DPP-4抑制剂可能减轻阿尔茨海默病的病理学.
- 在2型糖尿病患者中,DPP-4抑制剂显示出减缓痴呆症进展的潜力.
- 需要进行更大规模的研究来验证这些结果并确认治疗潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511